Valuable recombinant therapeutic proteins are routinely produced from Chinese hamster ovary (CHO) cells in fed-batch cultivations. An improved understanding of the physiological factors that affect cell proliferation, survival, productivity and product quality in fed-batch could contribute to facilitate general access to these products. This work describes the investigation of autophagy and glutamine metabolism in CHO cells for the purpose of increasing fed-batch process performance. The close link between glutamine deprivation and autophagy was found to greatly affect process performance, with an increase of the cellular lysosomal compartment correlated with decreased cell-specific productivity. The increased autophagic activity upon gluta...
Mammalian cells are widely used for the production of a variety of biopharmaceuticals, such as monoc...
<p>(A) The cells were cultured (a) in DMEM complete medium for 6 hr; (b) in L-glutamine-free DMEM fo...
Chinese hamster ovary (CHO) cells are the primary platform for commercial expression of recombinant ...
The majority of monoclonal antibodies (mAbs) are produced by fed-batch processes using Chinese Hamst...
Chinese hamster ovary (CHO) cells are the dominant host for producing biotherapeutic proteins. Despi...
Chinese hamster ovary (CHO) cells are preferred mammalian hosts for industrial production of therap...
Abstract Background The glycosylation of recombinant proteins can be altered by a range of parameter...
Chinese Hamster Ovary (CHO) cells are the preferred host systems for recombinant protein therapeutic...
To meet the ever-growing demand for effective, safe, and affordable protein therapeutics, decades of...
Much progress has been made in improving the viable cell density of bioreactor cultures in monoclona...
Because cells have adapted to respond to their extracellular environment, the in vitro conditions un...
Chinese hamster ovary (CHO) cells are the primary platform for commercial expression of recombinant ...
<div><p>Monoclonal antibody producing Chinese hamster ovary (CHO) cells have been shown to undergo m...
Monoclonal antibody producing Chinese hamster ovary (CHO) cells have been shown to undergo metabolic...
Various producer cell lines used for large scale production of biopharmaceuticals like monoclonal an...
Mammalian cells are widely used for the production of a variety of biopharmaceuticals, such as monoc...
<p>(A) The cells were cultured (a) in DMEM complete medium for 6 hr; (b) in L-glutamine-free DMEM fo...
Chinese hamster ovary (CHO) cells are the primary platform for commercial expression of recombinant ...
The majority of monoclonal antibodies (mAbs) are produced by fed-batch processes using Chinese Hamst...
Chinese hamster ovary (CHO) cells are the dominant host for producing biotherapeutic proteins. Despi...
Chinese hamster ovary (CHO) cells are preferred mammalian hosts for industrial production of therap...
Abstract Background The glycosylation of recombinant proteins can be altered by a range of parameter...
Chinese Hamster Ovary (CHO) cells are the preferred host systems for recombinant protein therapeutic...
To meet the ever-growing demand for effective, safe, and affordable protein therapeutics, decades of...
Much progress has been made in improving the viable cell density of bioreactor cultures in monoclona...
Because cells have adapted to respond to their extracellular environment, the in vitro conditions un...
Chinese hamster ovary (CHO) cells are the primary platform for commercial expression of recombinant ...
<div><p>Monoclonal antibody producing Chinese hamster ovary (CHO) cells have been shown to undergo m...
Monoclonal antibody producing Chinese hamster ovary (CHO) cells have been shown to undergo metabolic...
Various producer cell lines used for large scale production of biopharmaceuticals like monoclonal an...
Mammalian cells are widely used for the production of a variety of biopharmaceuticals, such as monoc...
<p>(A) The cells were cultured (a) in DMEM complete medium for 6 hr; (b) in L-glutamine-free DMEM fo...
Chinese hamster ovary (CHO) cells are the primary platform for commercial expression of recombinant ...